Clinical trials
Active, not recruiting Multiple Endocrine Neoplasia Type 1 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Elidah, Inc. | 1 |
| J.M. de Laat | 1 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Murdoch Childrens Research Institute | 1 |
| RTI International | 1 |
| The Hospital for Sick Children | 1 |
| University Hospital, Bordeaux | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Endocrine Neoplasia Type 1 | 8 |
| Adenoma, Islet Cell | 1 |
| Neuroendocrine Tumors | 1 |
| Obesity | 1 |
| Prostatic Hyperplasia | 1 |
| Urinary Incontinence | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.